0001628280-26-008603
SEC filingIngredion Incorporated reported strong financial results for the fiscal year ended December 31, 2025, demonstrating solid operational execution. The company generated net sales of $7.22 billion and achieved a gross profit of $1.83 billion, resulting in a gross margin of approximately 25.3%. Operating income totaled $1.02 billion, supported by $24.0 million in other operating income, despite incurring $21.0 million in restructuring and impairment charges. Net income attributable to Ingredion reached $729.0 million, translating to earnings per share of $11.00 on both a basic and diluted basis. The balance sheet remains robust with total assets of $7.90 billion and total stockholders' equity of $4.29 billion. Cash flow generation was particularly strong, with cash provided by operating activities totaling $944.0 million. The company returned significant capital to shareholders, paying $211.0 million in dividends and repurchasing $224.0 million of common stock. The firm maintained a disciplined approach to capital allocation, investing $433.0 million in capital expenditures while managing total debt levels of approximately $1.79 billion.
Ingredion Incorporated delivered solid financial performance for the fiscal year ended December 31, 2025. The company reported net sales of $7.22 billion and cost of sales of $5.39 billion, generating a gross profit of $1.83 billion. Operating income reached $1.02 billion, reflecting a 14.1% operating margin. After accounting for financing costs of $37.0 million and other non-operating expenses, income before income taxes totaled $974.0 million. The provision for income taxes was $238.0 million, resulting in a net income of $736.0 million. Net income attributable to Ingredion shareholders was $729.0 million, with $7.0 million attributable to non-controlling interests. Earnings per common share stood at $11.00 for both basic and diluted weighted average shares outstanding of 64.2 million and 65.2 million, respectively.
The filing discloses consolidated net sales of $7.22 billion for the fiscal year 2025. Detailed segment breakdowns, geographic revenue distribution, or specific growth drivers were not provided in the XBRL financial data or the document content supplied. Consequently, a granular analysis of revenue contributions by business unit or region cannot be presented. The revenue figure represents the aggregate performance of the company's operations in ingredient solutions for the reported period.
Ingredion maintained healthy profitability metrics during the fiscal year. The gross margin stood at approximately 25.3%, calculated from gross profit of $1.83 billion on $7.22 billion in sales. The operating margin was 14.1%, derived from operating income of $1.02 billion. Profitability was impacted by $21.0 million in restructuring and impairment charges and $815.0 million in operating expenses. The effective tax rate was approximately 24.4%, based on a provision of $238.0 million on pre-tax income of $974.0 million. Net income margin was approximately 10.1%.
The company demonstrated robust cash generation capabilities. Cash provided by operating activities was $944.0 million. Capital expenditures and mechanical stores purchases totaled $433.0 million, resulting in a free cash flow of approximately $511.0 million. On the balance sheet, total assets were $7.90 billion, including cash and cash equivalents of $1.03 billion. Total liabilities were $3.53 billion, comprising $48.0 million in short-term borrowings and $1.74 billion in long-term debt. Total stockholders' equity was $4.29 billion, resulting in a conservative debt-to-equity position.
The provided XBRL financial data and document content do not contain specific forward-looking statements, management guidance, or strategic priorities for the upcoming fiscal periods. Risk factors and future outlook commentary were not included in the source material. Therefore, an assessment of management's expectations or strategic direction cannot be provided based solely on the available financial figures.